Iopydone

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 596279

CAS#: 5579-93-1

Description: Iopydone is an iodinated contrast dye.


Chemical Structure

img
Iopydone
CAS# 5579-93-1

Theoretical Analysis

MedKoo Cat#: 596279
Name: Iopydone
CAS#: 5579-93-1
Chemical Formula: C5H3I2NO
Exact Mass: 346.83
Molecular Weight: 346.890
Elemental Analysis: C, 17.31; H, 0.87; I, 73.17; N, 4.04; O, 4.61

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Iopydone; Hytrast; Iopydonum; NSC 135284; NSC-135284; NSC135284;

IUPAC/Chemical Name: 3,5-diiodopyridin-4(1H)-one

InChi Key: FRPFEVLOFNAKBS-UHFFFAOYSA-N

InChi Code: InChI=1S/C5H3I2NO/c6-3-1-8-2-4(7)5(3)9/h1-2H,(H,8,9)

SMILES Code: O=C1C(I)=CNC=C1I

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 346.89 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Watanabe A, Saka H, Hasegawa Y, Shimokata K. [Survey of the state of bronchography in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Feb;33(2):127-31. Japanese. PubMed PMID: 7731115.

2: Bétrémieux P, Tréguier C, Pladys P, Bourdinière J, Leclech G, Lefrancois C. Tracheobronchography and balloon dilatation in acquired neonatal tracheal stenosis. Arch Dis Child Fetal Neonatal Ed. 1995 Jan;72(1):F3-7. PubMed PMID: 7743281; PubMed Central PMCID: PMC2528410.

3: Ginai AZ, Ten Kate FJ, Ten Berg RG, Hoornstra K. Intraperitoneal toxicity of Hytrast: an experimental study. Br J Radiol. 1986 Nov;59(707):1079-82. PubMed PMID: 3790893.

4: Lehner K, Gullotta U. [Late complication following Hytrast bronchography. In vivo dilution as a cause of severe alveolarization?]. Prax Klin Pneumol. 1985 Apr;39(4):133-5. German. PubMed PMID: 4001085.

5: Ginai AZ, ten Kate FJ, ten Berg RG, Hoornstra K. Experimental evaluation of various available contrast agents for use in the upper gastrointestinal tract in case of suspected leakage. Effects on lungs. Br J Radiol. 1984 Oct;57(682):895-901. PubMed PMID: 6487960.

6: Gallo E, Romagnoli R, Marchetti M. [Technical and radiological methodology problems in the diagnosis of H-shaped esophagotracheal fistulae]. Radiol Med. 1980 Jan-Feb;66(1-2):61-2. Italian. PubMed PMID: 7455206.

7: DE BRUIN CD. [COMPLICATIONS FOLLOWING BRONCHOGRAPHY WITH HYTRAST]. Ned Tijdschr Geneeskd. 1965 Apr 17;109:758-60. Dutch. PubMed PMID: 14320734.

8: MISENER FJ, QUINLAN JJ, HILTZ JE. HYTRAST: A NEW CONTRAST MEDIUM FOR BRONCHOGRAPHY. Can Med Assoc J. 1965 Mar 20;92:607-10. PubMed PMID: 14264971; PubMed Central PMCID: PMC1928217.

9: GREENBERG SD, HALLMAN GL Jr, SPJUT HJ. PULMONARY TISSUE REACTION FOLLOWING HYTRAST BRONCHOGRAMS. Ann Otol Rhinol Laryngol. 1964 Dec;73:1095-107. PubMed PMID: 14239528.

10: LIGHT JP, OSTER WF. STUDY OF THE CLINICAL AND PATHOLOGIC REACTION TO THE BRONCHOGRAPHIC AGENT HYTRAST. Am J Roentgenol Radium Ther Nucl Med. 1964 Sep;92:615-22. PubMed PMID: 14217082.

11: LANG EK. A COMPARATIVE STUDY OF FEBRILE REACTIONS TO HYTRAST, AQUEOUS DIONOSIL, AND OILY DIONOSIL IN BRONCHOGRAPHY. Radiology. 1964 Sep;83:455-9. PubMed PMID: 14206632.

12: OKADA H, MATSUMURA K. [BRONCHOGRAPHY WITH A NEW SUSPENSION CONTRAST MEDIA (HYTRAST)]. Rinsho Hoshasen. 1964 Jun;9:451-5. Japanese. PubMed PMID: 14182156.

13: GREENBERG SD, HALLMAN GL Jr, SPJUT HJ. PULMONARY TISSUE REACTION FOLLOWING HYTRAST BRONCHOGRAMS. Trans Annu Meet Am Bronchoesophagol Assoc. 1964;44:106-19. PubMed PMID: 14270817.

14: LEROUX BT, DUNCAN JG. BRONCHOGRAPHY WITH HYTRAST. Thorax. 1964 Jan;19:37-43. PubMed PMID: 14105882; PubMed Central PMCID: PMC1018797.

15: LAMY P, SENOT R, ANTHOINE D, JACQUIN B, RFBEIX G, BERTHEAU JM. [VALUE OF A NEW CONTRAST MEDIUM IN BRONCHOLOGY, AG 41-123 (HYTRAST)]. Ann Med Nancy. 1963 Nov;2:1523-31. French. PubMed PMID: 14111516.

16: WEBB WR, FITTS CT. EVALUATION OF HYTRAST AS A BRONCHOGRAPHIC MEDIUM. Am Surg. 1963 Jul;29:491-5. PubMed PMID: 14046051.

17: RAYL DF, SPJUT HJ. Bronchographic crystalline-inclusion pneumonia due to Hytrast. Radiology. 1963 Apr;80:588-604. PubMed PMID: 13973325.